PBE - Invesco Biotechnology & Genome Etf
NYSE
$81.17
+$1.52 (+1.91%)
About Invesco Biotechnology & Genome Etf
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.
PBE Key Statistics
Market Cap
$0.00M
How PBE Compares to Peers
P/E Rank
N/A
of 1
Margin Rank
N/A
of 1
Growth Rank
N/A
of 1
Size Rank
N/A
of 1